Decision Resources Inc

Akorn is a vertically integrated pharmaceutical company that focuses on specialty markets that include ophthalmology, anesthesia, antidotes and rheumatology. It is a specialty pharmaceutical company engaged in the development, manufacturing and marketing of branded and multi-source pharmaceutical products. As a specialty pharmaceutical company, Akorn is focused on three major business segments. These three segments are ophthalmology, hospitals and contract manufacturing. With a historical revenue base of more than $50 million, Akorn s eye is on the future. The company serves a wide variety of customers in the health care field. It has contract manufacturing strategic relationships with large pharmaceutical organizations such as Pfizer, Baxter, Novartis and B. Braun. Akorn has a location in Somerset, N.J.

PhaseBio Pharmaceuticals, located in Malvern, PA, is dedicated to developing innovative therapies for cardiovascular diseases, which currently affect one in four individuals. The company aims to address the pressing need for new treatment options by leveraging high-quality science and the expertise of its team to create a unique pipeline of medicines. Committed to improving patient outcomes and enhancing the healthcare system, PhaseBio focuses on overcoming the challenges associated with serious cardiovascular conditions. Their mission underscores a determination to deliver specialized therapies that can provide superior results for patients in need. Generated from the website

The 33, 000 square foot ( Capacity to expand up to 65, 000 square foot ) state of the art facility is located in Pennsylvania. It is organized to accommodate the entire business operation including product development, manufacturing, packing/labeling and quality control laboratory. Manufacturing operations, facilities and documentation comply with current good manufacturing practices ( cGMP's ). KVK-TECH is registered with Food and Drug Administration ( FDA ), Drug Enforcement Administration ( DEA ) and Department of Environmental Protection ( DEP ). The company is committed to developing solid dosage forms that include immediate and modified release tablets, capsules, liquids and semisolid dosage forms. Our products are available throughout the United States from Pharmaceutical wholesalers, distributors, chain drug stores and managed care organizations.